On this page
- Immunosuppressive medication remains essential
- What follow-up is needed after the first year?
- Protecting the kidneys, heart and metabolism
- Long-term infection prevention and vaccination
- Skin and cancer prevention
- Bones, muscles and quality of life
- When should I call before my scheduled appointment?
- A simple annual checklist
- See also
After the first year following a liver transplant, most people can lead an active life that feels much more like the one they had before becoming ill. Follow-up changes at this stage. The focus is no longer mainly on recovery from surgery, but on protecting the transplanted liver and preventing problems that may emerge over the years.
Feeling well does not mean that follow-up is no longer needed. Immunosuppressive medication, regular tests, vaccination and attention to blood pressure, kidney function, weight, bone health and skin are all part of long-term treatment.
In my experience, many people feel completely normal again after the first year. That is exactly what the transplant is intended to achieve, but it can also make appointments and medication seem less necessary. I always explain that caring for the new liver is mainly about maintaining a simple, consistent routine over many years.
Immunosuppressive medication remains essential
Medicines such as tacrolimus, cyclosporine, mycophenolate, everolimus and corticosteroids reduce the immune response to prevent rejection. Most people need them for life, although doses usually decrease over time. Complete withdrawal is considered only in exceptional circumstances under the supervision of an expert transplant team.
To use them safely:
- Take them every day at the prescribed time. Alarms and a pill organizer can help.
- Do not change the dose, brand or schedule on your own.
- If you miss a dose, vomit after taking it or take the wrong amount, follow your transplant center’s instructions. Do not double a dose unless told to do so.
- Before starting an antibiotic, antifungal, pain reliever, supplement or herbal product, check for interactions.
- Tell every clinician, including dentists and emergency staff, that you take immunosuppressants.
Some medicines and foods can substantially raise or lower tacrolimus or cyclosporine levels. Grapefruit and St John’s wort are well-known examples. Anti-inflammatory medicines such as ibuprofen, diclofenac and naproxen should also be avoided unless your clinical team specifically recommends them, because they can harm the kidneys.
What follow-up is needed after the first year?
Frequency depends on how long ago the transplant took place, the original liver disease, current medication and previous results. A stable person may have blood tests every few months and less frequent appointments, but follow-up should continue throughout life.
Follow-up usually covers:
- Liver tests: aminotransferases, alkaline phosphatase, GGT and bilirubin.
- Kidney function: creatinine, estimated glomerular filtration rate and, when appropriate, urine protein.
- Complete blood count, electrolytes and the blood level of the immunosuppressant.
- Blood pressure, weight and waist circumference.
- Blood glucose or hemoglobin A1c and cholesterol.
- Vaccination, bone health, skin and age-appropriate cancer screening.
Abnormal liver tests do not automatically mean rejection. Bile duct problems, infection, medication, fatty liver disease or recurrence of the original condition can also cause them. The transplant team will decide whether to repeat tests or arrange imaging, viral studies or a liver biopsy.
Protecting the kidneys, heart and metabolism
High blood pressure, diabetes, high cholesterol, weight gain and reduced kidney function are common after liver transplantation. Some risk was present before surgery, and some may be related to immunosuppressive medication. These conditions often progress without symptoms, so monitoring them matters as much as checking the liver.
A Mediterranean-style diet rich in vegetables, legumes, fruit, whole grains and fish, with fewer ultra-processed foods, can help manage weight and cardiovascular risk. Activity should be tailored to the individual. A reasonable general goal is to work toward 150 minutes of moderate exercise each week and add strength exercise twice weekly, if your health allows.
Do not adjust immunosuppression yourself in an attempt to improve blood pressure, diabetes or kidney function. The transplant team can change doses or combinations when the expected benefit outweighs the risk of rejection.
Long-term infection prevention and vaccination
The risk of infection is lower than during the first few months but remains higher than in someone who is not immunosuppressed. Wash your hands, avoid higher-risk raw or undercooked foods and seek advice before travel that may require special vaccination.
Keep influenza, COVID-19, pneumococcal, tetanus, hepatitis A and B, shingles and other age-appropriate vaccines up to date. The schedule should be reviewed with the transplant team because additional doses or boosters may be needed. Live vaccines, including yellow fever, measles, rubella and varicella, are generally not given after transplantation without specialist assessment.
A fever of 38°C (100.4°F) or higher, persistent chills or symptoms of a worsening infection are reasons to contact your clinical team. Do not stop immunosuppression during an infection unless instructed to do so.
Skin and cancer prevention
Immunosuppression raises the risk of certain cancers, particularly skin cancer. Use broad-spectrum sunscreen with SPF 30 or higher, a hat and protective clothing. Check for changing moles, wounds that do not heal and new skin lesions, and have dermatology examinations as often as your individual risk requires.
Continue usual preventive screening, including mammography, cervical screening, colonoscopy and prostate assessment according to age and history. Not smoking is one of the most effective ways to lower both cancer and cardiovascular risk. People transplanted for hepatocellular carcinoma also need an individualized imaging and laboratory surveillance plan.
Bones, muscles and quality of life
Osteoporosis may begin before transplantation and can persist beyond the first year. Bone density testing may be recommended according to age, previous results, corticosteroid exposure and other risk factors. Strength exercise, adequate dietary calcium and correction of vitamin D deficiency can help, but supplements should be chosen only after reviewing kidney function and blood tests.
Many people can return to work, travel, exercise and have a normal sex life. If pregnancy is desired, plan it in advance with the transplant team. Some medicines, particularly mycophenolate, can harm a developing fetus and must be replaced well ahead of time under medical supervision.
When should I call before my scheduled appointment?
Contact your transplant team if you develop:
- Jaundice, dark urine or very pale stools.
- Fever, chills or a worsening infection.
- Vomiting or diarrhea that prevents you from keeping medication down.
- A marked reduction in urine, swelling or rapid weight gain.
- Persistent abdominal pain, severe unexplained fatigue or new itching.
- A significant immunosuppressant dosing error or a newly prescribed medicine with possible interactions.
Chest pain, severe difficulty breathing, loss of consciousness or a sudden neurological deficit require emergency care.
A simple annual checklist
At least once a year, review your full medication list, vaccines, blood pressure and cardiovascular risk, kidney function, skin health, cancer screening and bone health with your clinical team. Keep an up-to-date medication list and the transplant center’s contact details with you.
Liver transplantation can restore both years and quality of life. After the first year, protecting that result depends less on extraordinary measures than on good coordination among the transplant center, hepatologist and primary care team, together with habits that can be sustained over time.
See also
References
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines on liver transplantation. J Hepatol. 2024;81(6):1040-1086.
- Shetty A, Kodali S. Long-Term Management of the Successful Adult Liver Transplant: A Patient-Friendly Summary of the 2012 AASLD and AST Practice Guideline. Clin Liver Dis (Hoboken). 2022;19(3):83-88.
- Neuberger JM, et al. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the COMMIT Group. Transplantation. 2017;101(4S Suppl 2):S1-S56.
- Danziger-Isakov L, Kumar D, AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13563.
- Raja K, Panackel C. Post Liver Transplant Renal Dysfunction: Evaluation, Management and Immunosuppressive Practice. J Clin Exp Hepatol. 2024;14(2):101306.
- Abate EG, et al. Five-year evaluation of bone health in liver transplant patients: developing a risk score for predicting bone fragility progression beyond the first year. Front Endocrinol (Lausanne). 2025;16:1467825.